Adagio Medical Holdings (ADGM) Enterprise Value (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Enterprise Value data on file, last reported at -$12.9 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 0.77% year-over-year to -$12.9 million; the trailing twelve-month figure through Mar 2026 stood at -$12.9 million (up 0.77% YoY), and the FY2025 full-year result was -$17.1 million, up 16.91% from the prior year.
• Enterprise Value improved to -$12.9 million in Q1 2026, from -$17.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$1.4 million in Q4 2023 to a low of -$28.3 million in Q3 2024.
• A 4-year average of -$13.3 million and a median of -$13.0 million in 2025 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value sank 1388.5% in 2024 and surged 83.46% in 2025, its largest moves.
• Tracing ADGM's Enterprise Value over 4 years: stood at -$1.4 million in 2023, then slumped by 1388.5% to -$20.6 million in 2024, then gained by 16.91% to -$17.1 million in 2025, then gained by 24.58% to -$12.9 million in 2026.
• Business Quant data shows ADGM's Enterprise Value at -$12.9 million in Q1 2026, -$17.1 million in Q4 2025, and -$4.7 million in Q3 2025.